Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 5;73(7):e2334-e2337.
doi: 10.1093/cid/ciaa1904.

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018

Collaborators, Affiliations

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018

Jennifer S Lee et al. Clin Infect Dis. .

Abstract

From 2005 to 2018, among 32013 adults with human immunodeficiency virus entering care, median time to antiretroviral therapy (ART) prescription declined from 69 to 6 days, CD4 count at entry into care increased from 300 to 362 cells/μL, and CD4 count at ART prescription increased from 160 to 364 cells/μL.

Keywords: CD4 count; HIV; antiretroviral therapy; treat all; universal treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Median CD4 count at entry into care (black circles) and at antiretroviral therapy (ART) prescription (red triangles) overlaying median days from entry into care to ART prescription (blue bars) by calendar year.

References

    1. Kitahata MM, Gange SJ, Abraham AG, et al. ; NA-ACCORD Investigators . Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815–26. - PMC - PubMed
    1. Panel of Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at https://aidsinfo.nih.gov/guidelines/archive/adult-and-adolescent-guideli.... Accessed 29 July 2020.
    1. World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV;2015. Available at https://apps.who.int/iris/handle/10665/186275. Accessed 31 July 2020.
    1. Gange SJ, Kitahata MM, Saag MS, et al. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 2007; 36:294–301. - PMC - PubMed
    1. Althoff KN, Buchacz K, Hall HI, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 2012; 157:325–35. - PMC - PubMed

Publication types

Substances

Grants and funding